Fundraising FoxAcuamark Diagnostics
New York, US · Founded 2012 · Delaware corporation · 3 known investors
Find your way into Acuamark Diagnostics
Sign up to see every warm intro you have to Acuamark Diagnostics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Acuamark Diagnostics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
BP
Bernard PeperstraeteExecutiveHe previously led ACT Biotech, a cancer pharmaceutical company acquired by Eddingpharm, and spent nearly a decade in healthcare venture capital as a partner at NGN Capital, with prior roles including emerging market work at Novartis, hospital leadership in Singapore, and positions in pharmaceutical management at Bristol Myers Squibb and Tan Tock Seng Hospital. He holds an MBA from Harvard and trained as a physician specializing in tropical medicine.
Board
WG
William GedaleBoard director
MH
Michael HanburyBoard director
BC
Brian CarrBoard director
DW
David WeavilBoard director
MG
Michael GarganoBoard director
HJ
Howard JohnsonBoard director
Investors · 3
Also in the syndicate · 3
BrukerBruker CorporationDel Vecchio Family Foundationlead
Reported raises · per SEC filings
Form D private placements$20.3M disclosed across 4 rounds · 2016–2024
▶$4.9MraisedJun 2024 · 20 investors · Other Health CareRule 506(b)
▶$4.9MraisedJun 2024 · 20 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Bernard PeperstraeteExecutive Officer, Director
- Cedric FrancoisDirector
- Claudio Del VecchioDirector
- Vanja VuleticDirector
- William GedaleDirector
- Giulia KennedyDirector
- Offering amount
- $12M
- Amount sold
- $4.9M
- Sales commissions
- $125K
- Finders' fees
- $84.1K
- Placement agents
- Finalis Securities LLC
- First sale
- May 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$11.6MraisedApr 2022 · 41 investors · Other Health CareRule 506(b)
▶$11.6MraisedApr 2022 · 41 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Cedric FrancoisDirector
- Claudio Del VecchioDirector
- Bernard PeperstraeteExecutive Officer, Director, Promoter
- William GedaleDirector
- Vanja VuleticDirector
- Offering amount
- $13.6M
- Amount sold
- $11.6M
- Finders' fees
- $148.8K
- First sale
- Mar 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.3MraisedSep 2019 · 29 investors · OtherRule 506(b)
▶$2.3MraisedSep 2019 · 29 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- William GedaleDirector
- Howard JohnsonDirector
- Gregory MurdockDirector
- Vanja VuleticDirector
- Michael GarganoDirector
- Bernard PeperstraeteExecutive Officer, Director, Promoter
- Joseph SmithDirector
- Offering amount
- $5.3M
- Amount sold
- $2.3M
- First sale
- Sep 2019
- Incorporated
- Corporation, New York, 2017
- Federal exemptions
- 06b
▶$1.5MraisedNov 2016 · 20 investors · Other TechnologyRule 506(b)
▶$1.5MraisedNov 2016 · 20 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Michael HanburyDirector
- Brian CarrDirector
- David WeavilDirector
- Michael GarganoDirector
- Howard JohnsonDirector
- William GedaleDirector
- Bernard PeperstraeteExecutive Officer, Director
- Offering amount
- $1.7M
- Amount sold
- $1.5M
- First sale
- Sep 2016
- Incorporated
- Corporation, New York, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Acuamark Diagnostics raised?
- Acuamark Diagnostics has disclosed $20.3M raised across 4 rounds.
- Where is Acuamark Diagnostics headquartered?
- Acuamark Diagnostics is headquartered in New York, US.